Latest Insider Transactions at Bausch Health Companies Inc. (BHC)
This section provides a real-time view of insider transactions for Bausch Health Companies Inc. (BHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch Health Companies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch Health Companies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+9.73%
|
$30,276
$29.32 P/Share
|
|
Jun 30
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+1.24%
|
$30,276
$29.32 P/Share
|
|
Jun 30
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,300
+1.04%
|
$37,700
$29.32 P/Share
|
|
Jun 30
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.24%
|
$6,786
$29.32 P/Share
|
|
Jun 11
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,000
-12.7%
|
$527,000
$31.68 P/Share
|
|
Jun 02
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
121,198
-42.09%
|
$3,757,138
$31.83 P/Share
|
|
Jun 02
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
121,198
+19.22%
|
$1,696,772
$14.85 P/Share
|
|
Jun 01
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,673
+20.1%
|
-
|
|
May 26
2021
|
Amy B Wechsler Director |
SELL
Open market or private sale
|
Direct |
11,037
-10.09%
|
$342,147
$31.79 P/Share
|
|
Apr 30
2021
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+2.44%
|
-
|
|
Apr 30
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+47.31%
|
-
|
|
Apr 30
2021
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+8.43%
|
-
|
|
Apr 30
2021
|
Argeris N Karabelas Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+7.88%
|
-
|
|
Apr 30
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+46.95%
|
-
|
|
Apr 30
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+8.52%
|
-
|
|
Apr 30
2021
|
Robert N Power Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+7.01%
|
-
|
|
Apr 30
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+5.87%
|
-
|
|
Apr 30
2021
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+7.24%
|
-
|
|
Apr 30
2021
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+17.03%
|
-
|
|
Apr 30
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+6.53%
|
-
|
|
Apr 30
2021
|
David Robert Hale Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+29.04%
|
-
|
|
Mar 31
2021
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,070
+0.36%
|
$33,170
$31.74 P/Share
|
|
Mar 31
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
126
+12.65%
|
$3,906
$31.74 P/Share
|
|
Mar 31
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+12.98%
|
$4,588
$31.74 P/Share
|
|
Mar 31
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
952
+1.26%
|
$29,512
$31.74 P/Share
|
|
Mar 31
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,188
+1.02%
|
$36,828
$31.74 P/Share
|
|
Mar 31
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
216
+0.21%
|
$6,696
$31.74 P/Share
|
|
Mar 22
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
744
+50.0%
|
-
|
|
Mar 22
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
744
+46.85%
|
-
|
|
Mar 11
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
796
-0.48%
|
$25,472
$32.82 P/Share
|
|
Mar 10
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
21,960
-11.59%
|
$702,720
$32.97 P/Share
|
|
Mar 10
2021
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,480
-7.05%
|
$559,360
$32.97 P/Share
|
|
Mar 10
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,361
-6.84%
|
$235,552
$32.97 P/Share
|
|
Mar 10
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
12,461
-10.12%
|
$398,752
$32.97 P/Share
|
|
Mar 10
2021
|
Paul Herendeen EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,519
-13.34%
|
$1,904,608
$32.97 P/Share
|
|
Mar 10
2021
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
231,188
-18.19%
|
$7,398,016
$32.97 P/Share
|
|
Mar 08
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
25,980
+12.06%
|
-
|
|
Mar 08
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,455
+4.92%
|
-
|
|
Mar 08
2021
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,144
+10.2%
|
-
|
|
Mar 08
2021
|
Thomas Appio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,161
+4.0%
|
-
|
|
Mar 08
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,530
+11.17%
|
-
|
|
Mar 08
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,404
+4.47%
|
-
|
|
Mar 08
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
17,320
+12.33%
|
-
|
|
Mar 08
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
5,637
+5.06%
|
-
|
|
Mar 08
2021
|
Paul Herendeen EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
50,518
+10.17%
|
-
|
|
Mar 08
2021
|
Paul Herendeen EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,324
+11.09%
|
-
|
|
Mar 08
2021
|
Joseph C Papa Director |
BUY
Grant, award, or other acquisition
|
Direct |
108,254
+7.85%
|
-
|
|
Mar 08
2021
|
Joseph C Papa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
317,089
+21.42%
|
-
|
|
Mar 03
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
36,250
+18.95%
|
-
|
|
Mar 03
2021
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,626
+13.41%
|
-
|